|
1
|
Liao W, Fu Z, Zou Y, Wen D, Ma H, Zhou F,
Chen Y, Zhang M and Zhang W: MicroRNA-140-5p attenuated oxidative
stress in Cisplatin induced acute kidney injury by activating
Nrf2/ARE pathway through a Keap1-independent mechanism. Exp Cell
Res. 360:292–302. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Sandborn WJ, van Assche G, Reinisch W,
Colombel JF, D'Haens G, Wolf DC, Kron M, Tighe MB, Lazar A and
Thakkar RB: Adalimumab induces and maintains clinical remission in
patients with moderate-to-severe ulcerative colitis.
Gastroenterology. 142:257–265. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Hua F, Ribbing J, Reinisch W, Cataldi F
and Martin S: A pharmacokinetic comparison of anrukinzumab, an
anti- IL-13 monoclonal antibody, among healthy volunteers, asthma
and ulcerative colitis patients. Br J Clin Pharmacol. 80:101–109.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Oliva S, Di Nardo G, Ferrari F, Mallardo
S, Rossi P, Patrizi G, Cucchiara S and Stronati L: Randomised
clinical trial: The effectiveness of Lactobacillus reuteri ATCC
55730 rectal enema in children with active distal ulcerative
colitis. Aliment Pharmacol Ther. 35:327–334. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
American Society for Reproductive: Revised
American Society for Reproductive Medicine classification of
endometriosis: 1996. Fertil Steril. 67:817–821. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Yamamoto Y, Hosoda K, Imahori T, Tanaka J,
Matsuo K, Nakai T, Irino Y, Shinohara M, Sato N, Sasayama T, et al:
Pentose phosphate pathway activation via HSP27 phosphorylation by
ATM kinase: A putative endogenous antioxidant defense mechanism
during cerebral ischemia-reperfusion. Brain Res. 1687:82–94. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Xia N, Chen G, Liu M, Ye X, Pan Y, Ge J,
Mao Y, Wang H, Wang J and Xie S: Anti-inflammatory effects of
luteolin on experimental autoimmune thyroiditis in mice. Exp Ther
Med. 12:4049–4054. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Eissa N, Hussein H, Kermarrec L, Elgazzar
O, Metz-Boutigue MH, Bernstein CN and Ghia JE: Chromofungin (CHR:
CHGA47-66) is downregulated in persons with active ulcerative
colitis and suppresses pro-inflammatory macrophage function through
the inhibition of NF-κB signaling. Biochem Pharmacol. 145:102–113.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kim GD: Myricetin inhibits angiogenesis by
inducing apoptosis and suppressing PI3K/Akt/mTOR signaling in
endothelial cells. J Cancer Prev. 22:219–227. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Rocha GR, Salamanca Florez EJ, de Barros
AL, Lobo CIV and Klein MI: Effect of tt-farnesol and myricetin on
in vitro biofilm formed by Streptococcus mutans and Candida
albicans. BMC Complement Altern Med. 18:612018. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Cho BO, Yin HH, Park SH, Byun EB, Ha HY
and Jang SI: Anti-inflammatory activity of myricetin from Diospyros
lotus through suppression of NF-κB and STAT1 activation and
Nrf2-mediated HO-1 induction in lipopolysaccharide-stimulated
RAW264.7 macrophages. Biosci Biotechnol Biochem. 80:1520–1530.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Li JZ, Wang ZL, Xu WH, Li Q, Gao L and
Wang ZM: MicroRNA-495 regulates migration and invasion in prostate
cancer cells via targeting Akt and mTOR signaling. Cancer Invest.
34:181–188. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhao L, Qi Y, Xu L, Tao X, Han X, Yin L
and Peng J: MicroRNA-140-5p aggravates doxorubicin-induced
cardiotoxicity by promoting myocardial oxidative stress via
targeting Nrf2 and Sirt2. Redox Biol. 15:284–296. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Obora K, Onodera Y, Takehara T, Frampton
J, Hasei J, Ozaki T, Teramura T and Fukuda K: Inflammation-induced
miRNA-155 inhibits self-renewal of neural stem cells via
suppression of CCAAT/enhancer binding protein β (C/EBPβ)
expression. Sci Rep. 7:436042017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Eun JW, Kim HS, Shen Q, Yang HD, Kim SY,
Yoon JH, Park WS, Lee JY and Nam SW: MicroRNA-495-3p functions as a
tumour suppressor by regulating multiple epigenetic modifiers in
gastric carcinogenesis. J Pathol. 244:107–119. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Scott FI and Lichtenstein GR: Biosimilars
in the treatment of inflammatory bowel disease: Supporting evidence
in 2017. Curr Treat Options Gastroenterol. 16:147–164. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Lee H and Lee CS: Flavonoid myricetin
inhibits TNF-α-stimulated production of inflammatory mediators by
suppressing the Akt, mTOR and NF-κB pathways in human
keratinocytes. Eur J Pharmacol. 784:164–172. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Rosario M, French JL, Dirks NL, Sankoh S,
Parikh A, Yang H, Danese S, Colombel JF, Smyth M, Sandborn WJ, et
al: Exposure-efficacy relationships for vedolizumab induction
therapy in patients with ulcerative colitis or Crohn's disease. J
Crohn's Colitis. 11:921–929. 2017. View Article : Google Scholar
|
|
19
|
Xie J and Zheng Y: Myricetin protects
keratinocyte damage induced by UV through IκB/NFκb signaling
pathway. J Cosmet Dermatol. 16:444–449. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Allamneni C, Venkata K, Yun H, Xie F,
DeLoach L and Malik TA: comparative effectiveness of vedolizumab
vs. infliximab induction therapy in ulcerative colitis: Experience
of a real-world cohort at a tertiary inflammatory bowel disease
center. Gastroenterol Res. 11:41–45. 2018. View Article : Google Scholar
|
|
21
|
Robbins L, Zaghiyan K, Melmed G,
Vasiliauskas E, Ahmed S, McGovern D, Rabizadeh S, Singh N, Landers
C, Ippoliti A, et al: Outcomes with anti-tumour necrosis
factor-alpha therapy and serology in patients with denovo Crohn's
disease after ileal pouch anal anastomosis. J Crohn's Colitis.
11:77–83. 2017. View Article : Google Scholar
|
|
22
|
Yuan CX, Zhou ZW, Yang YX, He ZX, Zhang X,
Wang D, Yang T, Pan SY, Chen XW and Zhou SF: Danusertib, a potent
pan-Aurora kinase and ABL kinase inhibitor, induces cell cycle
arrest and programmed cell death and inhibits epithelial to
mesenchymal transition involving the PI3K/Akt/mTOR-mediated
signaling pathway in human gastric cancer AGS and NCI-N78 cells.
Drug Des Devel Ther. 9:1293–1318. 2015.PubMed/NCBI
|
|
23
|
Gu P, Zhu L, Liu Y, Zhang L, Liu J and
Shen H: Protective effects of paeoniflorin on TNBS-induced
ulcerative colitis through inhibiting NF-kappaB pathway and
apoptosis in mice. Int Immunopharmacol. 50:152–160. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Tavares M, de Lima C, Fernandes W,
Martinelli V, de Lucena M, Lima F, Telles A, Brandão L and de Melo
Júnior M: Tumour necrosis factor-alpha (−308G/A) promoter
polymorphism is associated with ulcerative colitis in Brazilian
patients. Int J Immunogenet. 43:376–382. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Yu ZH, Huang F, Xu N, Zhao DM, Hu FA, Liu
J and Liu HF: Expression of Toll-like receptor 4, CD14, and NF-κB
in Chinese patients with ulcerative colitis. J Immunoassay
Immunochem. 32:47–56. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Gálvez-Llompart M, Recio MC and
García-Domenech R: Topological virtual screening: A way to find new
compounds active in ulcerative colitis by inhibiting NF-κB. Mol
Divers. 15:917–926. 2011. View Article : Google Scholar : PubMed/NCBI
|
